MyFitStrip LLC
MyFitStrip is a precision wellness platform advancing oral and metabolic health by restoring nitric oxide (NO) bioavailability through clinically grounded, microbiome-directed interventions. Built on validated nitrate–nitrite–NO biology, MyFitStrip uses topical oral delivery (chewing gums and lozenges) to enhance nitric oxide production directly within the oral microbiome—supporting beneficial bacteria (e.g., Neisseria, Rothia, Veillonella) while suppressing pathogenic species linked to inflammation, caries, and infection risk. This approach targets a critical physiological pathway, with evidence linking nitric oxide to vascular function, immune defense, and metabolic health, including improvements in endothelial function, blood pressure regulation, antimicrobial activity, and oral pH balance. The platform is complemented by rapid saliva-based test strips that measure nitric oxide status, pH, and uric acid—creating a closed-loop system that drives personalization, compliance, and real-time lifestyle feedback. MyFitStrip’s product suite includes prebiotic chewing gums, slow-release lozenges, and diagnostic strips, all supported by a portfolio of nitric oxide–related patents and a deep body of clinical and scientific research spanning immunology, cardiovascular health, and microbiome science. MyFitStrip is defining a new category at the intersection of oral microbiome modulation and nitric oxide biology, enabling scalable, non-invasive solutions for oral-systemic health optimization.
Industries
Nr. of Employees
small (1-50)
MyFitStrip LLC is currently seeking investment
MyFitStrip LLC is seeking a growth-stage investment in the range of 5m-20m
Patents
Methods and compositions for alleviating respiratory dysfunction
2023-12-19 • US-11844811-B2
View Details
Methods and compositions for alleviating respiratory dysfunction
2023-12-19 • US-11844811-B2
View DetailsProducts
Prebiotic nitrate chewing gum (plant-derived formulation)
Plant-derived chewing gum formulated with prebiotic nitrate sources (organic celery juice), antioxidant fruit concentrates and excipients intended to increase oral nitrate availability, raise salivary pH and promote nitrate‑reducing oral bacteria.
Prebiotic nitrate chewing gum (professional formulation)
Slow-release compressed gum containing prebiotic nitrate, xylitol, ascorbate and zinc intended to prolong residence time of actives in the oral cavity and shift oral microbiome composition.
Saliva nitric oxide (nitrite) test strips
Single-analyte saliva test strips that detect nitrite-related markers to indicate activity of nitrate-reducing oral microbiota and dietary nitrate uptake.
Saliva uric acid test strips
Non-invasive saliva test strips for rapid detection of salivary uric acid levels to support hydration and dietary behavior adjustments.
Saliva pH + prebiotic nitrate test strips (oral health)
Dual-function saliva strips measuring salivary pH and presence of prebiotic nitrate to assess oral acidity and nitrate availability for oral‑health optimization.
Prebiotic nitrate chewing gum (plant-derived formulation)
Plant-derived chewing gum formulated with prebiotic nitrate sources (organic celery juice), antioxidant fruit concentrates and excipients intended to increase oral nitrate availability, raise salivary pH and promote nitrate‑reducing oral bacteria.
Prebiotic nitrate chewing gum (professional formulation)
Slow-release compressed gum containing prebiotic nitrate, xylitol, ascorbate and zinc intended to prolong residence time of actives in the oral cavity and shift oral microbiome composition.
Saliva nitric oxide (nitrite) test strips
Single-analyte saliva test strips that detect nitrite-related markers to indicate activity of nitrate-reducing oral microbiota and dietary nitrate uptake.
Saliva uric acid test strips
Non-invasive saliva test strips for rapid detection of salivary uric acid levels to support hydration and dietary behavior adjustments.
Saliva pH + prebiotic nitrate test strips (oral health)
Dual-function saliva strips measuring salivary pH and presence of prebiotic nitrate to assess oral acidity and nitrate availability for oral‑health optimization.
Expertise Areas
- Saliva-based point-of-care diagnostics
- Oral microbiome modulation and prebiotic strategies
- Prebiotic nitrate formulation for oral delivery
- Non-invasive metabolic biomarker monitoring
Key Technologies
- Saliva colorimetric test strips
- Nitrite/nitrate detection assays
- Saliva uric acid assays
- Saliva pH measurement
Key People
News & Updates
Oral and systemic wellness share many common risk factors, including nitric oxide deficiency. A critical step in restoring oral and systemic health is dependent upon a functional oral microbiome capable of converting dietary prebiotic nitrate to nitric oxide.
Systemic vascular health is greatly influenced by our oral health and a functional prebiotic nitrate chewing gum may provide a consumer-friendly means that optimizes a nitric oxide favorable oral microbiome.
MyFitStrip observed that chewing slow-release functional chewing gums infused with a patent-pending formula of inorganic prebiotic nitrate and ascorbate shifts the oral microbiome towards a nitric oxide favorable microbiota. As important, the nitric oxide chewing gum also diminishes bacteria often associated with poor oral and systemic wellness.
Aside from enhancing nitric oxide-promoting bacteria, several investigators have reported that salivary nitrate lowers the incidence of tooth decay and gum inflammation.
The U.S. Patent and Trademark Office has issued U.S. Patent Number 11,844,811 on methods and compositions for alleviating respiratory dysfunction and improving nitric oxide bioavailability to MyFitStrip LLC.
Nasal airway generated nitric oxide provides an innate or natural defense against respiratory infections. Unfortunately, nitric oxide production can be compromised as we age and age-related chronic conditions and infections can suppress nitric oxide production. Boosting oral-nasal nitric oxide can elevate resistance against respiratory infections, including COVID, and elevated levels have been associated with fewer symptoms of respiratory conditions.
MyFitStrip granted U.S. patent for both assessing nitric oxide with saliva test strips and improving nitric oxide levels in subjects with nitric oxide deficiencies and symptoms of respiratory conditions with dietary prebiotic nitrate and vitamin C as a means to enhance nitric oxide bioavailability.
Both oral and systemic health outcomes may improve by simply extending the residence or ‘hang time’ of prebiotic nitrate formulations in the oral cavity to improve cardiometabolic complications that exhibit dysbiosis and low nitric oxide bioavailability because of poor dietary nitrate compliance.
Clinical studies outcome may usher in new drug design and disease targeting based on nitric oxide through inhalation, immune adjuvants, and dietary approaches.
SARS-CoV-2 is emerging as a thrombotic and vascular disease targeting endothelial cells throughout the body and is particularly evident in patients with cardiometabolic comorbidities, in particular hypertension, with associated endothelial dysfunction.
A hallmark of endothelial dysfunction and thrombotic events is suppressed endothelial nitric oxide synthase (eNOS) with concomitant nitric oxide deficiency. In healthy vessels, the endothelium releases the vasodilator and antithrombotic factor, nitric oxide. Whereas in injured vessels, nitric oxide is impaired contributing to hypertension and thrombus formation.
Restoring nitric oxide, independent of eNOS, may counter endotheliitis and contribute to pulmonary vasodilation, antithrombotic, and direct antiviral activity.
Nitric oxide is naturally produced by the body and is best known for blood pressure homeostasis. In 1998, the Nobel Prize in Medicine was awarded to three scientists for discovering nitric oxide’s role as a key signaling molecule in the cardiovascular system. Nitric oxide is equally vital in our immune system. Viruses, mycobacteria, protozoans, bacteria, and fungi are among a growing list of microbes that are susceptible to nitric oxide. As a matter of fact, a series of in vitro studies have reported that nitric oxide inhibits SARS-CoV replication and interferes with viral infection.
Oral and systemic wellness share many common risk factors, including nitric oxide deficiency. A critical step in restoring oral and systemic health is dependent upon a functional oral microbiome capable of converting dietary prebiotic nitrate to nitric oxide. Systemic vascular health is greatly influenced by our oral health and a functional prebiotic nitrate chewing gum may provide a consumer-friendly means that optimizes a nitric oxide favorable oral microbiome. MyFitStrip observed that chewing slow-release functional chewing gums infused with a patent-pending formula of inorganic prebiotic nitrate and ascorbate shifts the oral microbiome towards a nitric oxide favorable microbiota. As important, the nitric oxide chewing gum also diminishes bacteria often associated with poor oral and systemic wellness. Aside from enhancing nitric oxide-promoting bacteria, several investigators have reported that salivary nitrate lowers the incidence of tooth decay and gum inflammation.
The U.S. Patent and Trademark Office has issued U.S. Patent Number 11,844,811 on methods and compositions for alleviating respiratory dysfunction and improving nitric oxide bioavailability to MyFitStrip LLC. Nasal airway generated nitric oxide provides an innate or natural defense against respiratory infections. Unfortunately, nitric oxide production can be compromised as we age and age-related chronic conditions and infections can suppress nitric oxide production. Boosting oral-nasal nitric oxide can elevate resistance against respiratory infections, including COVID, and elevated levels have been associated with fewer symptoms of respiratory conditions. MyFitStrip granted U.S. patent for both assessing nitric oxide with saliva test strips and improving nitric oxide levels in subjects with nitric oxide deficiencies and symptoms of respiratory conditions with dietary prebiotic nitrate and vitamin C as a means to enhance nitric oxide bioavailability.
Both oral and systemic health outcomes may improve by simply extending the residence or ‘hang time’ of prebiotic nitrate formulations in the oral cavity to improve cardiometabolic complications that exhibit dysbiosis and low nitric oxide bioavailability because of poor dietary nitrate compliance.
Clinical studies outcome may usher in new drug design and disease targeting based on nitric oxide through inhalation, immune adjuvants, and dietary approaches.
SARS-CoV-2 is emerging as a thrombotic and vascular disease targeting endothelial cells throughout the body and is particularly evident in patients with cardiometabolic comorbidities, in particular hypertension, with associated endothelial dysfunction. A hallmark of endothelial dysfunction and thrombotic events is suppressed endothelial nitric oxide synthase (eNOS) with concomitant nitric oxide deficiency. In healthy vessels, the endothelium releases the vasodilator and antithrombotic factor, nitric oxide. Whereas in injured vessels, nitric oxide is impaired contributing to hypertension and thrombus formation. Restoring nitric oxide, independent of eNOS, may counter endotheliitis and contribute to pulmonary vasodilation, antithrombotic, and direct antiviral activity.
Nitric oxide is naturally produced by the body and is best known for blood pressure homeostasis. In 1998, the Nobel Prize in Medicine was awarded to three scientists for discovering nitric oxide’s role as a key signaling molecule in the cardiovascular system. Nitric oxide is equally vital in our immune system. Viruses, mycobacteria, protozoans, bacteria, and fungi are among a growing list of microbes that are susceptible to nitric oxide. As a matter of fact, a series of in vitro studies have reported that nitric oxide inhibits SARS-CoV replication and interferes with viral infection.